Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | S100A4 | P26447 | 2/20 | 0.43 |
| ▸ | PTPRC | P08575 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | APAF1 | O14727 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29623123 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TDP1HSD17B10GPR35PTPN1 | |
| SCHEMBL29614987 | 0.84 | HSD17B10 (0.54) | ALDH1A1TDP1HSD17B10GPR35MEN1 | |
| SCHEMBL28117 | 0.84 | HSD17B10 (0.54) | ALDH1A1TDP1HSD17B10GPR35MEN1 | |
| SCHEMBL1287837 | 0.82 | ALDH1A1 (0.74) | ALDH1A1TDP1HSD17B10GPR35PTPN1 | |
| SCHEMBL30535903 | 0.82 | ALDH1A1 (0.74) | ALDH1A1TDP1HSD17B10GPR35PTPN1 | |
| SCHEMBL29337140 | 0.80 | ALDH1A1 (0.71) | ALDH1A1TDP1HSD17B10GPR35PTPN1 | |
| SCHEMBL30987815 | 0.80 | ALDH1A1 (0.71) | ALDH1A1TDP1HSD17B10GPR35PTPN1 | |
| Ammonia Solution, Strong SCHEMBL9060371 | 0.80 | ALDH1A1 (0.71) | ALDH1A1TDP1HSD17B10GPR35PTPN1 | |
| SCHEMBL910658 | 0.77 | ENPP2 (0.50) | MAPTAPAF1 | |
| SCHEMBL5038826 | 0.76 | CES2 (0.48) | ALDH1A1TDP1HSD17B10GAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250098532-A1 | NITROGENOUS COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2025-03-20 | — | — | US | disclosed |
| EP-4281455-A1 | NITROGENOUS COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2023-11-29 | — | — | EP | disclosed |
| CN-116710454-A | Nitrogen-containing compounds for organic electroluminescent devices | 默克专利有限公司 | 2023-09-05 | — | — | CN | disclosed |
| WO-2022157343-A1 | NITROGENOUS COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-07-28 | — | — | WO | disclosed |
| EP-3544986-B1 | BRIDGED TRIARYLAMINES FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2020-12-23 | — | — | EP | disclosed |
| EP-3544986-A1 | BRIDGED TRIARYLAMINES FOR ELECTRONIC DEVICES | Merck Patent GmbH (DE) | 2019-10-02 | — | — | EP | disclosed |
| WO-2018095839-A1 | BRIDGED TRIARYLAMINES FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250098532-A1 | NITROGENOUS COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | NCL, NES, NPM1 | ALDH1A1 2452/4885TDP1 2490/4885HSD17B10 4220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.